Asset Details
Do you wish to reserve the book?
Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects
Do you wish to request the book?
Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects
2026
Overview
Regulatory T cells (Tregs) play a central role in maintaining immune homeostasis. Therefore, owing to their unique immunomodulatory function, their adoptive transfer has been investigated as a novel therapeutic modality. Recent progress in cell manufacturing has allowed the application of Tregs as cell therapy products, and several are being tested in human clinical trials. Furthermore, several clinical trials are aimed at evaluating Treg modulation methods, including cytokine administration, monoclonal antibodies, Treg depletion, and adoptive Treg transfer. Among these, adoptive Treg transfer is a promising cell and gene therapy modality that is potentially beneficial for both genetic and non-genetic diseases, including autoimmunity. To determine the current trends in research on Treg-based therapies, we performed a database search and found that investigational clinical trials have been performed not only for autoimmunity but also for a wide range of diseases. In this mini review, we introduce early benchmarking Treg trials together with recent advances in research on Treg biology shown in non-genetic diseases and not just limited to autoimmunity.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Animals
/ Autoimmune Diseases - immunology
/ Autoimmune Diseases - therapy
/ Biology
/ Cancer
/ Cell- and Tissue-Based Therapy - methods
/ Diabetes
/ good manufacturing practice (GMP)
/ Humans
/ Immunotherapy, Adoptive - methods
/ Lupus
/ Mutation
/ T-Lymphocytes, Regulatory - immunology
/ T-Lymphocytes, Regulatory - metabolism
/ T-Lymphocytes, Regulatory - transplantation
/ Translational Research, Biomedical
/ Tumors
